Skip to content

Effectiveness of a multilateral weight reduction conception

Effectiveness of a multilateral weight reduction conception

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000325
Enrollment
120
Registered
2010-02-01
Start date
2009-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.0

Interventions

Group 1: verum group: intake of two fatbinding tablets per day Group 2: Placebo group: intake of two placebo tablets per day

Sponsors

Leibniz Universität Hannover Institut für Lebensmittelwissenschaft und Ökotrophologie Abteilung Ernährungsphysiologie und Humanernährung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: - caucasian men and women at the age of 30-60 years - Body Mass Index between 28,0 and 35,0 kg/m² - proband's written agreement to investigation after oral and written education about study content, demands and risks - proband's willingness to replace one meal by a formula diet and to consume two fatbinding tablets per day - proband's willingness to follow the given recommendations concerning nutrition and physical acitvity

Exclusion criteria

Exclusion criteria: - severe chronic illness (manifest chd, cancer) - insulin-dependent diabetes mellitus Typ I and II - severe kidney or liver diseases - chronic gastroinestinal diseases (especially small intestine e.g. duodenal ulcer, liver, pancreas) and state after gastrointestinal surgical procedure e.g. nontropical sprue, short bowel syndrome) - stomach stapling operations, gastric band - known endokrine and immunological diseases - lactose malabsorption - intolerance towards soy and milk protein - continuous intake of laxatives - continuous intake of corticosteroids (not inhalation), psychotropic drugs - pregnancy - lactation - addiction to alcohol and/or drugs - immediate planned surgery - simultaneous participation at another clinical trial or participation within the last 30 days - missing consent - refusing / reset of the consent

Design outcomes

Primary

MeasureTime frame
body weight, BMI at any appointment (week 0, week 6, week 12, week 18)

Secondary

MeasureTime frame
waist circumference, Bioelectrical impedance analysis, blood pressure, several blood parameters (e.g. glucose, insulin, TC, HDL, LDL, TG), questionnaire at any appointment (week 0, week 6, week 12, week 18)

Countries

Germany

Contacts

Public ContactJanina Postler

Leibniz Universität Hannover Institut für Lebensmittelwissenschaft und Ökotrophologie Abteilung Ernährungsphysiologie und Humanernährung

postler@nutrition.uni-hannover.de0049 (0)511 762 - 5755

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026